Y Lin, X Zheng, Y Chen, Q Nian, L Lin, M Chen - Heliyon, 2024 - cell.com
In this study, we delved into the safety profile of alpelisib, an FDA-approved treatment for
hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced or metastatic breast …